20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with beta-escin in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
---|---|---|---|---|---|
640 | 13 | 233 | 580 | 72 | 148 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Echave, V; Gomes, MM; Guibert, C; Morin, C; Rousseau, E; Sirois, M | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and beta-escin
Article | Year |
---|---|
Effects of omega-hydroxylase product on distal human pulmonary arteries.
Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Escin; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isometric Contraction; Muscle Proteins; Muscle Relaxation; Muscle, Smooth, Vascular; Peptides; Phosphoprotein Phosphatases; Potassium Channels, Calcium-Activated; Protein Kinase C; Pulmonary Artery; Vascular Resistance | 2008 |